Multiple sclerosis associated with systemic sclerosis

Rheumatology International

Volumn 27, Issue 8, 2007, Pages 771-773

  Pelidou, Syngliti Henrietta ^a   Tsifetaki, Niki ^b   Giannopoulos, Sotiris ^a   Deretzi, Georgia ^a   Voulgari, Paraskevi ^b   Kyritsis, Athanassios ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

MS; Multiple sclerosis; SSc; Systemic sclerosis; T cells

Indexed keywords

BETA INTERFERON; CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHOTREXATE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HAND; HUMAN; HYPOPIGMENTATION; LABORATORY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENICITY; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RELAPSE; REMISSION; SCLERODERMA; SEROLOGY; SKIN TIGHTNESS; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY;

ADULT; AGE OF ONSET; FEMALE; HUMANS; MULTIPLE SCLEROSIS; SCLERODERMA, SYSTEMIC;

EID: 34248224700     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-006-0282-5     Document Type: Article

References (17)

1. Kinnunen E, Jarvinen P, Ketonen L, Sepponen R (1993) Co-twin control study on cerebral manifestations of systemic lupus erythematosus. Acta Neurol Scand 88(6):422-426
2. Mpofu S, Moots RJ (2003) A case of multiple sclerosis associated with rheumatoid arthritis and positive anticardiolipin antibodies. Ann Rheum Dis 62(4):376
3. Black CM (1993) Scleroderma - clinical aspects. J Intern Med 234:115-118
4. Jawad SH, Askari A, Ward AB (1997) Case history of a patient with multiple sclerosis and scleroderma. Br J Rheumatol 36:502-509
5. Spadaro A, Sensi F, Barrela M, Francia A (1999) Systemic sclerosis and multiple sclerosis. J Neurol 246(6):497-499
6. Chroni E, Paschalis C, Stergiou T, Vlahanastasi C, Andonopoulos AP (2002) Multiple sclerosis in the course of systemic sclerosis. Ann Rheum Dis 61(2):188-190
7. Gorodkin R, Leahy B, Neary D, Herrick AL (2004) Coexistence of systemic sclerosis and multiple sclerosis. J Neurol 251(12):1524-1525
8. Poser CM, Paty DW, Scheinberg L, Mc Donald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13(3):227-231
9. Rodriguez-Reyna TS, Alarcon-Segovia D (2005) Overlap syndromes in the context of shared autoimmunity. Autoimmunity 38(3):219-223
10. Seyfert S, Klapps P, Meisel C, Fischer T, Jungham U (1990) Multiple sclerosis and other immunologic diseases. Acta Neurol Scand 81:37-42
11. Theodoridou A, Settas L (2006) Demyelination in rheumatic diseases. J Neurol Neurosurg Psychiatry 77(3):290-295
12. Ram M, Sherer Y, Shoenfeld Y (2006) Matrix metalloproteinase-9 and autoimmune diseases. J Clin Immunol [Epub ahead of print]
13. Sakkas LI (2005) New developments in the pathogenesis of systemic sclerosis. Autoimmunity 38(2):113-116
14. Do HT, Baars W, Borns K, Windhagen A, Schwinzer R (2006) The 77C > G mutation in the human CD45 (PTPRC) gene leads to increased intensity of TCR signaling in T cell lines from healthy individuals and patients with multiple sclerosis. J Immunol 176(2):931-938
15. Johnson NA, Meyer CM, Pingel JT, Thomas ML (1989) Sequence conservation in potential regulatory regions of the mouse and human leukocyte common antigen gene. J Biol Chem 264:6220-6229
16. Trowbridge IS, Thomas ML (1994) CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol 12:85-116
17. Schwinzer R, Witte T, Hundrieser J, Ehlers S, Momot T, Hunzelmann N, Krieg T, Schmidt RE, Wonigeit K (2003) Enhanced frequency of a PTPRC (CD45) exon A mutation (77C→G) in systemic sclerosis. Genes Immun 4(2):168-169